ADVANCED MEDICINE PARTNERS Trademark Information
Number:
2521581
Ir number:
1839217
Words:
ADVANCED MEDICINE PARTNERS
Kind:
Word
Status group:
NEVER_REGISTERED
Status code:
Not protected
Status detail:
Not accepted
Priority date:
16 Jan 2024
Lodgement date:
16 Jul 2024
Ir notification date:
13 Feb 2025
Ir renewal due date:
16 Jul 2034
First report date:
11 Mar 2025
Acceptance due date:
11 Jun 2026
Renewal due date:
16 Jul 2034
Lapsed date:
11 Jun 2026
Filing date:
16 Jul 2024
Indexing constituents:
ADVANCED, MEDICINE, PARTNERSClass:
40,42
Convention details:
Array
Mark categories:
Trademark
Last status check:
2026-06-20 01:58:28
Status updated at:
2026-06-20 01:58:28
Goods and services:
1) Class: 40Description: Manufacture for others of pharmaceuticals, manufacture for others of products relating to biotechnology, manufacture for others of cell therapy products, manufacture for others of gene therapy products, pharmaceutical manufacturing in accordance with GMP regulations.
2) Class: 42
Description: Contract development and manufacturing organization (CDMO) services, consulting and advisory services in the field of analytical development and quality control testing of pharmaceutical, gene therapy, and cell therapy products, consulting and advisory services in the field of manufacturing process development for pharmaceutical, gene therapy and cell therapy products, consulting in the field of chemistry manufacturing and controls (CMC) activities, testing of pharmaceutical, gene therapy, and cell therapy products and materials, quality control testing of pharmaceutical products and materials, testing and validation services for pharmaceutical, cell therapy and gene therapy methods of development.
History and publication details:
1) Date: 2026-06-19
Display name: International Registration in Australia Refused correspondence sent
2) Date: 2026-06-18
Display name: Status change to Lapsed/Not Protected
3) Date: 2026-02-14
Display name: IRDA - Opposition Still Possible Notice correspondence sent
4) Date: 2025-04-05
Display name: Full Assignment - Subsequent Applicant Recorded Published
5) Date: 2025-04-03
Display name: Full Assignment Requested
6) Date: 2025-03-12
Display name: Adverse Report (Examination) correspondence sent
7) Date: 2025-03-11
Display name: IP Right has been Examined
8) Date: 2025-02-14
Display name: Awaiting examination
9) Date: 2025-02-14
Display name: Examination expedited
10) Date: 2025-02-13
Display name: IP Right Filed Published
11) Date: 2025-02-13
Display name: Status change to Published
12) Date: 2025-02-13
Display name: Status change to Filed
13) Date: 2025-02-13
Display name: Application Received
14) Date: 2025-02-13
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:40; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 40; 42
15) Date: 2025-02-13
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Contract development and manufacturing organization (CDMO) services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceutical, gene therapy, and cell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceutical, gene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceutical, gene therapy, and cell therapy products and materials; quality control testing of pharmaceutical products and materials; testing and validation services for pharmaceutical, cell therapy and gene therapy methods of development.
16) Date: 2025-02-13
Display name: IP Right Goods and Services Items updated
Description: Class Number: 40
Previous details:
New details: Class Number: 40 Class Items: Manufacture for others of pharmaceuticals; manufacture for others of products relating to biotechnology; manufacture for others of cell therapy products; manufacture for others of gene therapy products; pharmaceutical manufacturing in accordance with GMP regulations.
17) Date: 2025-02-13
Display name: Status change to Received
18) Date: 2025-02-13
Display name: Trade mark representation updated
Display name: International Registration in Australia Refused correspondence sent
2) Date: 2026-06-18
Display name: Status change to Lapsed/Not Protected
3) Date: 2026-02-14
Display name: IRDA - Opposition Still Possible Notice correspondence sent
4) Date: 2025-04-05
Display name: Full Assignment - Subsequent Applicant Recorded Published
5) Date: 2025-04-03
Display name: Full Assignment Requested
6) Date: 2025-03-12
Display name: Adverse Report (Examination) correspondence sent
7) Date: 2025-03-11
Display name: IP Right has been Examined
8) Date: 2025-02-14
Display name: Awaiting examination
9) Date: 2025-02-14
Display name: Examination expedited
10) Date: 2025-02-13
Display name: IP Right Filed Published
11) Date: 2025-02-13
Display name: Status change to Published
12) Date: 2025-02-13
Display name: Status change to Filed
13) Date: 2025-02-13
Display name: Application Received
14) Date: 2025-02-13
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:40; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 40; 42
15) Date: 2025-02-13
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Contract development and manufacturing organization (CDMO) services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceutical, gene therapy, and cell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceutical, gene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceutical, gene therapy, and cell therapy products and materials; quality control testing of pharmaceutical products and materials; testing and validation services for pharmaceutical, cell therapy and gene therapy methods of development.
16) Date: 2025-02-13
Display name: IP Right Goods and Services Items updated
Description: Class Number: 40
Previous details:
New details: Class Number: 40 Class Items: Manufacture for others of pharmaceuticals; manufacture for others of products relating to biotechnology; manufacture for others of cell therapy products; manufacture for others of gene therapy products; pharmaceutical manufacturing in accordance with GMP regulations.
17) Date: 2025-02-13
Display name: Status change to Received
18) Date: 2025-02-13
Display name: Trade mark representation updated
Owner Information
Owner structured address:
TWO CONWAY PARK, SUITE 300 LAKE FOREST IL 60045, UNITED STATES OF AMERICA
Owner is private:
0
